| Literature DB >> 35793137 |
Eakalak Lukkanalikitkul1, Sawinee Kongpetch1, Wijittra Chotmongkol1, Michael G Morley2, Sirirat Anutrakulchai3, Chavis Srichan4, Bandit Thinkhamrop5, Theenatchar Chunghom6, Pongsai Wiangnon6, Wilaiphorn Thinkhamrop5, Katharine E Morley7.
Abstract
BACKGROUND: The prevalence of peritoneal dialysis (PD) in Thailand is increasing rapidly in part because of Thailand's Peritoneal Dialysis First policy. PD is a home-based renal replacement therapy in which patients with chronic kidney disease perform up to 4 exchanges of dialysate fluid per day in the peritoneal cavity. Overhydration is one of the most common complications in patients on PD and is associated with increased morbidity and mortality. To monitor hydration status, patients collect hydration metrics, including body weight, blood pressure, urine output, and ultrafiltration volume, from each dialysis cycle and enter this information into a PD logbook. This information is reviewed bimonthly at PD clinic appointments. The chronic kidney disease-PD (CKD-PD) app with near-field communication (NFC) and optical character recognition (OCR) was developed to automate hydration metric collection. The information was displayed in the app for self-monitoring and uploaded to a database for real-time monitoring by the PD clinic staff. Early detection and treatment of overhydration could potentially reduce the morbidity and mortality related to overhydration.Entities:
Keywords: UTAUT; Unified Theory of Acceptance and Use of Technology; barrier; computer program; dialysis; home monitoring; interface; internal medicine; kidney; mHealth; methodology; metric capture; mobile health; mobile phone; monitor; near-field communication; nephrologist; nephrology; peritoneal; peritoneum; process improvement; quality improvement; rapid cycle improvement; rapid cycle process improvement methodology; renal; usability
Year: 2022 PMID: 35793137 PMCID: PMC9301552 DOI: 10.2196/37291
Source DB: PubMed Journal: JMIR Form Res ISSN: 2561-326X
Overview and timeline of research activities.
| Research activity | Phase 1 (group 1) | ICa 1 | Phase 2 (group 2) | IC 2 | Phase 3 (groups 1 and 2) | |||||||
|
| Week | Week | Week | Week | Week | |||||||
|
| 0 | 1-2 | 3 | 4 | 5-8 | 8 | 9-10 | 11 | 12 | 12-16 | 17-18 | 19-20 |
| In-clinic training and observation | ✓ |
|
|
|
| ✓ |
|
|
|
|
|
|
| UTAUTb survey | ✓ |
|
| ✓ |
| ✓ |
|
| ✓ |
| ✓ | ✓ |
| Home observation |
| ✓ |
|
|
|
| ✓ |
|
|
| ✓ | ✓ |
| Completion of hydration metrics |
|
| ✓ | ✓ |
|
|
| ✓ | ✓ |
|
| ✓ |
| Contact with PDc clinic |
|
| ✓ | ✓ |
|
|
| ✓ | ✓ |
|
| ✓ |
| Validation of hydration metrics |
|
|
| ✓ |
|
|
|
| ✓ |
|
| ✓ |
| Observation logbook |
|
|
|
|
|
|
|
|
|
| ✓ |
|
aIC: improvement cycle.
bUTAUT: Unified Theory of Acceptance and Use of Technology.
cPD: peritoneal dialysis.
Difference in Unified Theory of Acceptance and Use of Technology total scoresa by participant and domain between the beginning of phase 1 or 2 and end of phase 3 (detailed results in Multimedia Appendix 5).
| Participant numberb | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Values, mean | ||||||||||||
|
| |||||||||||||||||||||||
|
| Phase 1 or 2 | 89 | 63 | 86 | 81 | 87 | 79 | 66 | 75 | 71 | 77 | 77 | |||||||||||
|
| Phase 3 | 74 | 76 | 80 | 74 | 77 | 72 | N/Ac | 80 | 79 | 72 | 76 | |||||||||||
|
| Difference | −15 | 13 | −6 | −7 | −10 | −7 | N/A | 5 | 8 | −5 | −2.7 | |||||||||||
|
| |||||||||||||||||||||||
|
| Performance expectancy | −2 | 3 | 1 | 1 | −1 | −1 | N/A | 1 | 1 | 0 | 0.33 | |||||||||||
|
| Effort expectancy | −2 | 4 | 1 | −1 | 1 | −1 | N/A | 0 | 0 | 1 | 0.33 | |||||||||||
|
| Social influence | −3 | 3 | 1 | 0 | −2 | −1 | N/A | −1 | 1 | −1 | −0.67 | |||||||||||
|
| Voluntariness | −3 | −3 | −5 | −2 | −3 | −3 | N/A | 2 | 3 | −4 | −2 | |||||||||||
|
| Intention to use | −2 | 3 | −4 | −4 | −6 | 0 | N/A | 2 | 3 | 0 | −0.9 | |||||||||||
|
| Facilitating conditions | −3 | 3 | 0 | −1 | 1 | −1 | N/A | 1 | 0 | −1 | −0.1 | |||||||||||
aScores for individual questions from 1 (strongly disagree) to 5 (strongly agree). The domain scores ranged from 5 to 15. The total score for all the domains ranged from 30 to 90.
bParticipants 1 to 5: phase 1 and phase 3; participants 6 to 10: phase 2 and phase 3.
cN/A: not applicable; participant 7 expired before phase 3.
Feature and task ratingsa from participant observation in phases 1, 2, and 3 (detailed results in Multimedia Appendix 6).
| Feature | Phase 1b, mean (range) | Phase 2c, mean (range) | Phase 3d, mean (range) | Phase 3e, mean (range) |
| Open screens | 1.1 (1-2) | 1 (1) | 1.6 (1-3) | N/Af |
| Enter body weight | 1.1 (1-2) | 1.2 (1-2) | 1.1 (1-2) | 1.4 (1-2) |
| Enter blood pressure | 1.1 (1-2) | 1.6 (1-3) | 1.1 (1-2) | 1.4 (1-3) |
| Enter dialysate | 1.1 (1-2) | 1.2 (1-2) | 1.1 (1-2) | 1.8 (1-3) |
| View metrics | 1.3 (1-2) | 1 (1) | 1.1 (1-2) | 1.7 (1-3) |
| Interpret metrics | 1.1 (1-2) | 1.2 (1-2) | 1.1 (1-2) | N/A |
| Communications | 1 (1) | 1 (1) | 1 (1) | 1.2 (1-3) |
| User incentives | 1.1 (1-2) | 1.2 (1-2) | 1.2 (1-3) | 1.9 (1-3) |
aRating of task or feature: 1=good, 2=neutral, and 3=not good.
bGroup 1 using the chronic kidney disease–peritoneal dialysis app with near-field communication or optical character recognition data entry; participants 1 to 5.
cGroup 2 using the chronic kidney disease–peritoneal dialysis app with near-field communication or optical character recognition data entry; participants 6 to 10.
dGroup 1 and 2 using the chronic kidney disease–peritoneal dialysis app with manual entry; participants 1 to 10, excluding 7.
eGroup 1 and 2 using logbook; participants 1 to 10, excluding 7.
fN/A: not applicable.
Percentage completion of hydration metrics (detailed in Multimedia Appendix 7).
| Participant | Phase 1a | Phase 2b | Phase 3c | Difference (%)d | |||
|
| Total, N | Done, n (%) | Total, N | Done, n (%) | Total, N | Done, n (%) |
|
| 1 | 84 | 80 (95) | —e | — | 42 | 19 (45) | −50 |
| 2 | 66 | 39 (59) | — | — | 84 | 42 (50) | −9 |
| 3 | 42 | 42 (100) | — | — | 42 | 26 (62) | −38 |
| 4 | 84 | 73 (87) | — | — | 84 | 79 (94) | 7 |
| 5 | 48 | 48 (100) | — | — | 56 | 40 (71) | −29 |
| 6 | — | — | 42 | 38 (91) | 42 | 42 (100) | 9 |
| 7f | — | — | 39 | 35 (90) | N/Ag | N/A | N/A |
| 8 | — | — | 42 | 37 (88) | 42 | 39 (93) | 5 |
| 9 | — | — | 30 | 24 (57) | 84 | 15 (18) | −39 |
| 10 | — | — | 80 | 27 (90) | 42 | 33 (79) | −11 |
| Values, mean | 65 | 56 (88) | 46.6 | 32 (83) | 57.6 | 37 (68) | −15 |
aPhase 1: participants 1 to 5.
bPhase 2: participants 6 to 10.
cPhase 3: participants 1 to 10.
dDifference in percentage completion between phase 1 or 2 and phase 3.
eNot available.
fParticipant 7 expired before completion of the study.
gN/A: not applicable.
Validation of hydration metrics.
| Participant | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Values, n (%)a | ||||||||||||
|
| |||||||||||||||||||||||
|
| Body weight | Noc | No | No | No | No | —d | — | — | — | — | 0 (0) | |||||||||||
|
| Blood pressure | Yese | Yes | No | Yes | Yes | — | — | — | — | — | 4 (80) | |||||||||||
|
| Dialysate in | Yes | No | Yes | No | Yes | — | — | — | — | — | 3 (60) | |||||||||||
|
| Dialysate out | Yes | No | Yes | No | Yes | — | — | — | — | — | 3 (60) | |||||||||||
|
| Ultrafiltration volume | Yes | No | Yes | No | No | — | — | — | — | — | 2 (40) | |||||||||||
|
| |||||||||||||||||||||||
|
| Body weight | — | — | — | — | — | Yes | No | Yes | No | Yes | 3 (60) | |||||||||||
|
| Blood pressure | — | — | — | — | — | Yes | Yes | Yes | Yes | Yes | 5 (100) | |||||||||||
|
| Dialysate in | — | — | — | — | — | Yes | Yes | Yes | Yes | Yes | 5 (100) | |||||||||||
|
| Dialysate out | — | — | — | — | — | Yes | Yes | Yes | Yes | No | 4 (80) | |||||||||||
|
| Ultrafiltration volume | — | — | — | — | — | Yes | No | Yes | Yes | No | 3 (60) | |||||||||||
|
| |||||||||||||||||||||||
|
| Body weight | Yes | NDh | ND | Yes | Yes | Yes | N/Ai | Yes | Yes | Yes | 7 (100) | |||||||||||
|
| Blood pressure | Yes | Yes | Yes | Yes | Yes | Yes | N/A | Yes | Yes | Yes | 9 (100) | |||||||||||
|
| Dialysate in | Yes | Yes | Yes | Yes | Yes | Yes | N/A | Yes | Yes | Yes | 9 (100) | |||||||||||
|
| Dialysate out | Yes | Yes | Yes | Yes | Yes | Yes | N/A | Yes | Yes | Yes | 9 (100) | |||||||||||
|
| Ultrafiltration volume | Yes | Yes | Yes | Yes | Yes | Yes | N/A | Yes | Yes | ND | 9 (100) | |||||||||||
aNumber and percentage of hydration metric values entered and uploaded with the correct results to Chronic Kidney Disease Prevention in the Northeast of Thailand.
bPhase 1: participants 1 to 5.
cNot uploaded accurately to Chronic Kidney Disease Prevention in the Northeast of Thailand.
dNot available.
eUploaded accurately to Chronic Kidney Disease Prevention in the Northeast of Thailand.
fPhase 2: participants 6 to 10.
gPhase 3: participants 1 to 10.
hND: not done by participant.
iN/A: not applicable; participant 7 expired before completion of the study.
Number and reason for contacting the peritoneal dialysis clinic by phase.
| Phase | Total number of contacts, N | Clinical issue, n (%) | App issue, n (%) | Other, n (%) |
| Phase 1 | 104 | 0 (0) | 99 (95.2) | 5 (4.8) |
| Phase 2 | 13 | 3 (23.1) | 10 (76.9) | 0 (0) |
| Phase 3 | 22 | 13 (59.1) | 9 (40.9) | 0 (0) |